TROPHOCAN CVS CATHETER 4870-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 02,06 report with the FDA on 1996-11-14 for TROPHOCAN CVS CATHETER 4870-26 manufactured by Smiths Industries Medical Systems.

Event Text Entries

[24604] The pt underwent the cvs procedure and one transcervical pass was made. The pt spontaneously aborted at 14 weeks gestation.
Patient Sequence No: 1, Text Type: D, B5


[7770468] Co has received additional information from chief stenographer, at the user facility. Further investigation at the user facility found that the spontaneous pregnancy less reported was not due to the use of a co's product during the cvs procedure and was filed in error.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1217052-1996-00075
MDR Report Key48660
Report Source02,06
Date Received1996-11-14
Date of Report1996-10-15
Date Mfgr Received1996-10-15
Date Added to Maude1996-11-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTROPHOCAN CVS CATHETER
Generic NameCATHETER, SAMPLING, CHORIONIC VILLUS
Product CodeLLX
Date Received1996-11-14
Model NumberNA
Catalog Number4870-26
Lot NumberNI
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Age*
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key49425
ManufacturerSMITHS INDUSTRIES MEDICAL SYSTEMS
Manufacturer Address15 KIT ST KEENE NH 03431 US
Baseline Brand NameTROPHOCAN CVS CATHETER
Baseline Generic NameCATHETER, SAMPLING, CHORIONIC VILLUS
Baseline Model NoNA
Baseline Catalog No4870-26
Baseline IDNA
Baseline Device FamilyNA
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]60
Baseline PMA FlagY
Premarket ApprovalP8900
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1996-11-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.